Skip to main content
Log in

Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The efficacy of various charcoal-to-drug ratios for the absorption of drugs was studied in 6 healthy volunteers and in vitro at two pHs. Disopyramide 200 mg, indomethacin 50 mg and trimethoprim 200 mg were ingested on an empty stomach with 100 ml water. After 5 min the subjects ingested a charcoal suspension in 300 ml — 2.5 g, 10 g, 25 g or 50 g of Norit A, or 10 g of PX-21, or water 300 ml only. Increasing the dose of activated charcoal from 2.5 g to 50 g reduced the gastrointestinal absorption of disopyramide and indomethacin from 30–40% to 3–5%, and that of trimethoprim from 10% to 1% of the respective controls. Disopyramide and trimethoprim were best adsorbed by charcoal in vitro at neutral and indomethacin at acid pH, but saturation of the adsorption capacity was apparent at charcoal-to-drug ratios less than 7.5. Combining the in vitro and in vivo results it can be concluded that the dose of activated charcoal to be given in acute intoxication should be as large as possible, because the drug history is often unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andersen AH (1947) Experimental studies on the pharmacology of activated charcoal. II. The effect of pH on the adsorption by charcoal from aqueous solutions. Acta Pharmacol Toxicol (Copenh) 3: 199–218

    Google Scholar 

  2. Bartlett MS (1937) Some examples of statistical methods of research in agriculture and applied biology. J R Stat Soc (Suppl) 4: 137–183

    Google Scholar 

  3. Chin L, Picchioni AL, Bourn WM, Laird HE (1973) Optimal antidotal dose of activated charcoal. Toxicol Appl Pharmacol 26: 103–108

    Google Scholar 

  4. Chung DC, Murphy JE, Taylor TW (1982) In-vivo comparison of the adsorption capacity of “superactive charcoal” and fructose with activated charcoal and fructose. J Toxicol Clin Toxicol 19: 219–224

    Google Scholar 

  5. Cooney DO (1977) A “superactive” charcoal for antidotal use in poisonings. Clin Toxicol 11: 387–390

    Google Scholar 

  6. Cooney DO (1980) Activated charcoal. Dekker, New York, Basel, pp 43–46

    Google Scholar 

  7. Duncan DB (1955) Multiple range and multiple F tests. Biometrics 11: 1–42

    Google Scholar 

  8. Hayden JW, Comstock EG (1975) Use of activated charcoal in acute poisoning. Clin Toxicol 8: 515–533

    Google Scholar 

  9. Hayler AM, Holt DE, Volans GN (1978) Fatal overdosage with disopyramide. Lancet 1: 968–969

    Google Scholar 

  10. Holt LE Jr, Holz PH (1963) The black bottle. J Pediatr 63: 306–314

    Google Scholar 

  11. Hoppu K, Partanen S, Koskela E (1980) Trimethoprim poisoning. Lancet 1: 778

    Google Scholar 

  12. Klaassen CD (1980) Principles of toxicology. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics (6th ed). Macmillan, New York, p 1610

    Google Scholar 

  13. Levy G, Tsuchiya T (1972) Effect of activated charcoal on aspirin absorption in man. Clin Pharmacol Ther 13: 317–322

    Google Scholar 

  14. Levy G, Houston JB (1976) Effect of activated charcoal on acetaminophen absorption. Pediatrics 58: 432–435

    Google Scholar 

  15. Lin E, Benet LZ (1980) HPLC Assay for indomethacin. In: Sadée W, Beelen GCM (eds) Drug level monitoring. John Wiley & Sons, New York, p 281

    Google Scholar 

  16. Neuvonen PJ (1982) Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clin Pharmacokin 7: 465–489

    Google Scholar 

  17. Neuvonen PJ, Olkkola KT, Alanen T (1984) Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man. Acta Pharmacol Toxicol 54: 1–7

    Google Scholar 

  18. Queneau P, Barthelemy C, Fulchiron P (1978) Ingestion massive d'indométacine en prise unique. Therapie 33: 645–650

    Google Scholar 

  19. Skellern GG, Salole EG (1975) A high-speed liquid chromatographic analysis of indomethacin in plasma. J Chromatogr 114: 483–485

    Google Scholar 

  20. Swinyard EA (1970) Demulcents, emollients, protectives and absorbents. In: Goodman LS, Gilman A (eds) The Pharmacological basis of therapeutics (4th ed). Macmillan, New York, p 990

    Google Scholar 

  21. Vale JA, Meredith TJ (1981) Poisoning due to cardiovascular drugs. In: Vale JA, Meredith TJ (eds) Poisoning: diagnosis and treatment. Update Books, London, Dordrecht, Boston, pp 120–121

    Google Scholar 

  22. Volans GN (1981) General principles of treatment. In: Vale JA, Meredith TJ (eds) Poisoning: diagnosis and treatment. Update Books, London, Dordrecht, Boston, pp 31–32

    Google Scholar 

  23. Weinfeld RE, Macasieb TC (1979) Determination of trimethoprim in biological fluids by high-performance liquid chromatography. J Chromatogr 164: 73–84

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neuvonen, P.J., Olkkola, K.T. Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man. Eur J Clin Pharmacol 26, 761–767 (1984). https://doi.org/10.1007/BF00541939

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541939

Key words

Navigation